Please Wait
Applying Filters...
menu
    • menu
    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Synnat Pharma is one of the leading active pharmaceutical ingredients and intermediates manufacturers.

    Virtual Booth

    Contact Supplier

    Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    4-[3-(3-tert-butyl-4-pyrrolidin-1-ylphenyl)-4-(2-hydroxyethoxy)phenyl]benzoic acid

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    FDA Confirms Paragraph IV Patent Litigation for Trifarotene
    FDA Confirms Paragraph IV Patent Litigation for Trifarotene

    06 Dec 2023

    // FDA

    https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-litigation-for-trifarotene-48662.pdf

    FDA
    06 Dec 2023
    Share Share
    Galderma Acne treatment receives approval from Europe
    Galderma Acne treatment receives approval from Europe

    20 Dec 2019

    // PHARMAFILE

    http://www.pharmafile.com/news/536089/galderma-acne-treatment-receives-approval-europe

    PHARMAFILE
    20 Dec 2019
    Share Share
    Galderma Receives FDA Approval for AKLIEF® (trifarotene) Cream for Acne
    Galderma Receives FDA Approval for AKLIEF® (trifarotene) Cream for Acne

    07 Oct 2019

    // PRNEWS WIRE

    https://www.prnewswire.com/news-releases/galderma-receives-fda-approval-for-aklief-trifarotene-cream-0-005-the-first-new-retinoid-molecule-for-the-treatment-of-acne-in-over-20-years-300931400.html

    PRNEWS WIRE
    07 Oct 2019
    Share Share